EverSource Wealth Advisors’s Cidara Therapeutics CDTX Stock Holding History

EverSource Wealth Advisors’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-314	Closed	-$69.4K	–	4407
2025 Q4	$69.4K	Buy	+314	New	+$50.8K	﹤0.01%	1515

EverSource Wealth Advisors's CDTX Position: Q1 2026 in Review

EverSource Wealth Advisors sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 314 shares — an estimated $69.4K sold.

EverSource Wealth Advisors first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $69.4K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

EverSource Wealth Advisors reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
EverSource Wealth Advisors sold 314 Cidara Therapeutics shares in Q1 2026, an estimated $69.4K.
EverSource Wealth Advisors first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
EverSource Wealth Advisors's Cidara Therapeutics position peaked at $69.4K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.